Your new experience awaits. Try the new design now and help us make it even better

COMMUNITY CASE STUDY article

Front. Public Health

Sec. Infectious Diseases: Epidemiology and Prevention

This article is part of the Research TopicLeveraging Real-Time Genomic Surveillance to Combat Infectious Diseases and Antimicrobial ResistanceView all 18 articles

SeqAfrica: Empowering Africa's fight against antimicrobial resistance through genomics

Provisionally accepted
Pernille  NilssonPernille Nilsson1*Christa  Twyford GibsonChrista Twyford Gibson1Natasia  Rebekka ThornvalNatasia Rebekka Thornval1Niamh  Lacy-RobertsNiamh Lacy-Roberts1Christina  OdgaardChristina Odgaard1Christian  Owusu-NyantakyiChristian Owusu-Nyantakyi2Grebstad  Rabbi AmuasiGrebstad Rabbi Amuasi2William  BoatengWilliam Boateng2Quaneeta  MohktarQuaneeta Mohktar2Alfred  BorteyAlfred Bortey2Erkison  Ewomazino OdihErkison Ewomazino Odih3Gabriel  Temitope SunmonuGabriel Temitope Sunmonu3Happiness  Houka KumburuHappiness Houka Kumburu4Tolbert  SondaTolbert Sonda4Jinal  N BhimanJinal N Bhiman5,6,7,8Daniel Gyamfi  AmoakoDaniel Gyamfi Amoako10,5,9Mignon  du PlessisMignon du Plessis11,5Bright  AduBright Adu2Marco  van ZwetselaarMarco van Zwetselaar12,4Anne  von GottbergAnne von Gottberg11,5Blandina Theophil  MmbagaBlandina Theophil Mmbaga13,4Iruka  N OkekeIruka N Okeke3Anthony  SmithAnthony Smith14,15Beverly  EgyirBeverly Egyir2Rene  S HendriksenRene S Hendriksen1
  • 1Technical University of Denmark, National Food Institute, Research Group for Global Capacity Building, Kgs. Lyngby, Denmark
  • 2University of Ghana Noguchi Memorial Institute for Medical Research, Accra, Ghana
  • 3Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Oyo State, Ibadan, Nigeria
  • 4Kilimanjaro Clinical Research Institute, Moshi, Tanzania
  • 5Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Division of the National Health Laboratories Service, Johannesburg, South Africa
  • 6SAMRC Antibody Immunity Research Unit, School of Pathology, University of Witwatersrand, Johannesburg, South Africa
  • 7National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa
  • 8Division of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
  • 9Antimicrobial Research Unit, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
  • 10Department of Pathobiology, University of Guelph, ON N1G 2W1, Guelph, Canada
  • 11Department of Clinical Microbiology and Infectious Diseases (CMID), School of Pathology, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa
  • 12Zwets IT, Harskamp, Netherlands
  • 13School of Medicine, KCMC University, Moshi, Tanzania
  • 14Centre for Enteric Diseases, National Institute for Communicable Diseases, Division of the National Health Laboratories Service, Johannesburg, South Africa
  • 15Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa

The final, formatted version of the article will be published soon.

The ongoing threat of antimicrobial resistance (AMR) demands capacity strengthening in Africa for improved pathogen surveillance. The high-resolution picture of AMR provided by pathogen whole genome sequencing (WGS) can help close data gaps and inform disease prevention strategies, interventions and public health actions. Here, we report on phase 1 of the Fleming Fund-supported SeqAfrica project (2019-2023), one of the first genomic AMR surveillance networks in Africa. SeqAfrica established five regional sequencing hubs across West, East, and Southern Africa, expanded infrastructure, and delivered hybrid training programs to strengthen workforce capacity. During phase 1, the network generated 29,269 pathogen genomes (18,264 bacterial, 300 fungal, and 10,705 SARS-CoV-2) from 21 African countries, contributing to 40 scientific publications and substantial genomic data for national and global surveillance efforts, supporting outbreak investigations and antimicrobial stewardship initiatives. The median turnaround time from sample receipt to data release was 12 weeks (range: 3-104 weeks), demonstrating the feasibility of genomic AMR surveillance despite logistical challenges. By nurturing a community of practice, expanding the workforce, and translating data into actionable insights, SeqAfrica has advanced the integration of pathogen genomics into national and regional surveillance frameworks. However, sustaining this capacity remains a challenge amid global funding constraints, procurement bottlenecks, and workforce retention issues. Lessons learned from implementation include successes in regional collaboration and persistent challenges in procurement, workforce retention, and metadata completeness, which informed the design of phase 2. As Africa continues to invest in genomic health infrastructure, SeqAfrica provides a proven model for embedding pathogen genomics into public health strategies and strengthening AMR surveillance across the continent.

Keywords: Africa, antimicrobial resistance, low- and middle-income countries, whole genomesequencing, surveillance, Capacity Building

Received: 30 Sep 2025; Accepted: 24 Nov 2025.

Copyright: © 2025 Nilsson, Gibson, Rebekka Thornval, Lacy-Roberts, Odgaard, Owusu-Nyantakyi, Amuasi, Boateng, Mohktar, Bortey, Odih, Sunmonu, Kumburu, Sonda, Bhiman, Amoako, du Plessis, Adu, van Zwetselaar, von Gottberg, Mmbaga, Okeke, Smith, Egyir and Hendriksen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Pernille Nilsson, pnil@food.dtu.dk

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.